TNFRSF9 and Parkinson disease: Importantly, the increase in LRRK2 is not a reflection of overall increases in protein content in immune cells in PD subjects vs. HCs as other cell-specific markers such as CD19, CD14, and 4-1BB were not significantly different between HC and PD subjects (Supplementary Fig. S2).